Advertisements
Read Time:7 Second
After Britain authorized a bivalent vaccine to target Omicron, some are wondering whether they should hold out for a similar shot in the U.S.
Happy
0
0 %
Sad
0
0 %
Excited
0
0 %
Sleepy
0
0 %
Angry
0
0 %
Surprise
0
0 %